Back to top

Court Dismisses Securities Lawsuit Against Zenas BioPharma Over IPO Disclosures 

A federal judge in Massachusetts has dismissed a securities lawsuit against Zenas BioPharma, Inc. (NASDAQ: ZBIO), ruling that the clinical-stage bi...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: